By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orion Genomics today said that it has licensed to Qiagen non-exclusive rights to its MethylScreen technology for epigenetics research.

Qiagen will use the MethylScreen technology in its EpiTect Methyl qPCR Array System reagent kits, which are used by researchers to analyze the DNA methylation status of genes with quantitative PCR.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.